Clinical Trial

Changes in Glucose Tolerance in Patients With Cirrhosis Peri-Liver Transplant

Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this observational study is to establish risk factors for post-transplant in adult individuals with cirrhosis without diabetes undergoing liver transplant evaluation. The question being addressed is: can laboratory work, anthropometric tests, functional tests, imaging, and advanced measurements such as wrist actigraphy, continuous glucose monitoring, or oral glucose tolerance testing predict the development of diabetes after liver transplant? Participants will be asked to periodically participate in wearing a continuous glucose monitor and wrist actigraph and obtain an oral glucose tolerance test both before and after liver transplant.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-04-22.
Trial Details
NCT Number NCT06950788
Lead Sponsor University of Chicago
Conditions Cirrhosis, Liver, Diabetes Mellitus Risk, Transplant; Failure, Liver, Transplant-Related Disorder
Enrollment 60 participants
Start Date 2024-03-12
Primary Completion 2027-06 (estimated)
Study Completion 2031-01 (estimated)
Updated on ClinicalTrials.gov 2026-05-07